Ortin Laboratories Ltd - ESG Rating & Company Profile powered by AI
This Disclosure rating includes seventeen UN Sustainable Development Goals including: 'Clean Water & Sanitation', 'Reduced Inequalities' and 'Partnerships for the Goals'. This report of Ortin Laboratories Ltd uses intelligence from across the web and also from public disclosures by Ortin Laboratories Ltd. Full ESG assessment of Ortin Laboratories Ltd are reached by signing up for free.
Ortin Laboratories Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 8.0 and governance score of 5.3.
7.1
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
217 | Takara Bio Inc | 7.2 | High |
217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
224 | Ortin Laboratories Ltd | 7.1 | High |
224 | Celularity Inc | 7.1 | High |
224 | Bilcare Ltd | 7.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Ortin Laboratories Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Ortin Laboratories Ltd disclose current and historical energy intensity?
Does Ortin Laboratories Ltd report the average age of the workforce?
Does Ortin Laboratories Ltd reference operational or capital allocation in relation to climate change?
Does Ortin Laboratories Ltd disclose its ethnicity pay gap?
Does Ortin Laboratories Ltd disclose cybersecurity risks?
Does Ortin Laboratories Ltd offer flexible work?
Does Ortin Laboratories Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Ortin Laboratories Ltd disclose the number of employees in R&D functions?
Does Ortin Laboratories Ltd conduct supply chain audits?
Does Ortin Laboratories Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Ortin Laboratories Ltd conduct 360 degree staff reviews?
Does Ortin Laboratories Ltd disclose the individual responsible for D&I?
Does Ortin Laboratories Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Ortin Laboratories Ltd disclose current and / or historical scope 2 emissions?
Does Ortin Laboratories Ltd disclose water use targets?
Does Ortin Laboratories Ltd have careers partnerships with academic institutions?
Did Ortin Laboratories Ltd have a product recall in the last two years?
Does Ortin Laboratories Ltd disclose incidents of discrimination?
Does Ortin Laboratories Ltd allow for Work Councils/Collective Agreements to be formed?
Has Ortin Laboratories Ltd issued a profit warning in the past 24 months?
Does Ortin Laboratories Ltd disclose parental leave metrics?
Does Ortin Laboratories Ltd disclose climate scenario or pathway analysis?
Does Ortin Laboratories Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Ortin Laboratories Ltd disclose the pay ratio of women to men?
Does Ortin Laboratories Ltd support suppliers with sustainability related research and development?
Does Ortin Laboratories Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Ortin Laboratories Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Ortin Laboratories Ltd involved in embryonic stem cell research?
Does Ortin Laboratories Ltd disclose GHG and Air Emissions intensity?
Does Ortin Laboratories Ltd disclose its waste policy?
Does Ortin Laboratories Ltd report according to TCFD requirements?
Does Ortin Laboratories Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Ortin Laboratories Ltd disclose energy use targets?
Does Ortin Laboratories Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Ortin Laboratories Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Ortin Laboratories Ltd
These potential risks are based on the size, segment and geographies of the company.
Ortin Laboratories Limited manufactures and trades in pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products. The company's formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, it offers active pharmaceutical ingredient (API) intermediates comprising anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, such as development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. The company was incorporated in 1986 and is headquartered in Hyderabad, India.